All Online

1 - 9 of 9 results

Refine

Active filters

Hyperlipidemia
1 CME CREDIT

In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.


1 CME CREDIT

This presentation will provide an updated on newer approaches to the management of lipid disorders for the primary and secondary prevention of atherosclerotic cardiovascular disease and hypertriglyceridemia-induced acute pancreatitis. It will also provide an evidence-based approach to the management of lipid disorders in special populations. The focus will be on the recommendations provided by the 2018 ACC/AHA Guidelines on the Treatment of Blood Cholesterol and the application of these clinical guidelines in patient care.


0.5 CME CREDIT

Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman in this webcast to find out.


1.25 CME CREDITS

National lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, explore novel targets and treatment pathways, and apply the 2018 AHA/ACC Cardiology Cholesterol Guidelines. Learners will have gain practical clinical perspectives during expert case study discussions, including how new treatment options may fit into the current therapeutic landscape.


0.5 CME CREDIT

Watch distinguished faculty from Northwestern University examine clinical trial data and the latest evidence-based guidelines for hypercholesterolemia to help you develop a practical approach to lipid management for primary care. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 12, 2020, and they are subject to change as new information is published.


0.5 CME CREDIT

Hypercholesteremia is highly prevalent in the U.S. and strongly associated with cardiovascular morbidity and mortality. Yet, only about 55% of U.S. adults appropriate for cholesterol lowering therapy are currently taking it. What do primary care providers need to know to improve the care of the many individuals with hypercholesterolemia that you see daily in clinical practice? Join Dr. Ty Gluckman for part 2 of this webcast series to find out.


1 CME CREDIT

This initiative aims to increase understanding among cardiologists about adjunctive LDL-C-lowering therapies and their potential role in reducing residual ASCVD risk. During this series, national lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, and explore novel targets and treatment pathways. It is expected to improve cardiologists’ management of patients with ‘tough-to-treat’ cholesterol according to the 2018 American Heart Association (AHA)/American College of Cardiology (ACC)/Multi-society Cholesterol Guidelines. Learners will have the opportunity to gain practical clinical perspectives during expert case study discussions. The patient scenarios will discuss how new treatment options may fit into the current therapeutic landscape.


0.25 CME CREDIT

New Lipid Guidelines: What's the Skinny on Treating Blood Fats? - Frankly Speaking EP 106

Guest: Alan M. Ehrlich, MD FAAFP Music Credit: Richard Onorato

0.25 CME

Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added.


0.25 CME CREDIT

Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.